Hikma Pharmaceuticals USA Inc. v. Vanda Pharmaceuticals Inc.


Question(s) Presented

“The question presented is whether patents that claim a method of medically treating a patient automatically satisfy Section 101 of the Patent Act, even if they apply a natural law using only routine and conventional steps.”

Proceedings and Orders
October 31, 2018
Application (18A461) granted by The Chief Justice extending the time to file until December 27, 2018.
January 23, 2019
Motion to extend the time to file a response is granted and the time is extended to and including February 12, 2019.
February 27, 2019
DISTRIBUTED for Conference of 3/15/2019.
March 18, 2019
The Solicitor General is invited to file a brief in this case expressing the views of the United States.
December 23, 2019
DISTRIBUTED for Conference of 1/10/2020.
January 13, 2020
Petition DENIED.